Characterization Table for Human Hepatocytes - Cryoplateable

To view a specific table, Choose an option from the menu below.

ProductNo. LotNo. Description Age (yrs) Viability Confluence PHEN COUM BUP AMO TOLB MEPH DEX CZX TEST MID ECOD 7-HCG 7-HCS AO NAT1 Enzyme NAT2 Enzyme CYP1A2 (Enz) Induction CYP2B6 (Enz) Induction CYP3A4 (Enz) Induction CYP1A2 (mRNA) Induction CYP2B6 (mRNA) Induction CYP3A4 (mRNA) Induction 2D6 2C9 2C19 NAT1 Genotype NAT2 Genotype
M00995-P XVN Male 57 93% 85% 50 16 13 106 20 0.14 0.46 156 87 11 199 363 44 TBD TBD TBD 16 7 18 NT NT NT TBD TBD TBD TBD TBD
F00995-P BXW Female 73 90% 97% 5 69 17 196 26 0.20 21 27 67 15 82 514 44 259 TBD TBD 17 5 9 39 7 28 TBD TBD TBD TBD TBD
M00995-P GFR Male 38 93% 97% 40 33 11 213 52 2 1 18 27 11 69 540 62 246 TBD TBD 22 12 33 30 12 163 TBD TBD TBD TBD TBD
F00995-P DEA Female 39 82% 98% 1 74 44 92 14 2 16 16 15 5 30 355 21 160 TBD TBD 31 7 37 37 6 114 TBD TBD TBD TBD TBD
M00995-P OZJ Male 2 88% 98% 19 175 247 217 56 24 16 23 123 57 132 562 46 113 TBD TBD 15 10 7 85 18 66 TBD TBD TBD TBD TBD
M00995-P NDQ Male 54 94% 95% 18 4 5 149 21 0.69 36 30 47 15 104 574 54 189 TBD TBD 20 6 14 20 6 142 TBD TBD TBD TBD TBD
F00995-P TNX Female 8 months 86% 87% 17 132 28 161 45 BQL 18 38 44 28 94 521 32 TBD TBD TBD 8 9 27 29 15 175 TBD TBD TBD TBD TBD
F00995-P LYZ Female 34 95% 98% 11 53 10 202 22 3 0.38 21 37 14 61 433 54 192 TBD TBD 29 8 43 TBD TBD TBD TBD TBD TBD TBD TBD
F00995-P YNM Female 48 93% 85% 2 2 5 221 12 2 13 23 1 2 36 383 25 194 TBD TBD 8 8 22 TBD TBD TBD TBD TBD TBD TBD TBD
F00995-P YNZ Female 67 80% 98% 14 30 17 257 42 0 25 19 39 47 70 418 164 291 TBD TBD 13 9 12 TBD TBD TBD TBD TBD TBD TBD TBD
F00995-P EJP Female 11 90% 98% 17 55 32 198 62 30 40 10 105 37 68 467 41 TBD TBD TBD 10 7 13 TBD TBD TBD TBD TBD TBD TBD TBD
F00995-P TLY Female 2 months 91% 99% 3 9 6 135 185 14 19 161 53 13 146 267 89 TBD 13 1 5 10 23 75 10 96 TBD TBD TBD *4/*10 *5B/*5B
M00995-P MRW Male 11 months 85% 99% 16 0 5 128 46 18 6 30 65 14 49 366 39 TBD 5 2 7 8 29 45 24 58 TBD TBD TBD *10/*14A *4/*6A
M00995-P DUX Male 8 month 84% 96% 11 0 2 53 53 2 22 54 15 6 41 202 21 5 1 6 11 67 61 10 221 TBD TBD TBD *4/*4 *4/*6A
M00995-P UYL Male 34 84% 97% 3 33 23 135 100 0.25 29 50 37 22 128 405 51 TBD TBD 17 8 21 37 7 57 TBD TBD TBD TBD TBD
F00995-P AKB Female 39 94% 90% 23 7 NT NT 23 1 51 46 31 NT 136 372 46 TBD TBD 11 16 15 28.9 13.9 15.8 NT NT NT TBD TBD
M00995-P CML Male 38 89% 98% 23 16 64 114 58 2 66 64 34 11 260 371 43 NT NT 9 5 13 28 11 49 NT NT NT NT NT
F00995-P THM Female 80 78% 79% 30 40 5 104 51 40 14 53 21 21 147 518 42 TBD NT NT 15 7 20 47 10 44 NT NT NT NT NT
M00995-P EBS Male 59 92% 95% 23 4 4 141 39 9 46 22 21 9 91 430 55 8.73 0.77 16 11 5 33 39 26 TBD TBD TBD *4/*4 *4/*5B
M00995-P DOO Male 57 83% 92% 45 3 NT NT 29 1 76 82 41 NT 123 378 17 29 0.308 7 12 8 9 15 10 wt/wt wt/*3 wt/*2 *4/*4 *5B/*5B
F00995-P DQB Female 51 87% 82% 6 110 69 180 8 12 21 33 87 57 167 527 33 4.65 1.04 45 8 22 42 6 22 NT NT NT *4/*4 *5B/*5B
F00995-P ETA Female 80 85% 70% 4 83 NT NT 32 1 16 18 56 NT 25 15 7 0.218 2.085 22 NT 8 NT NT NT wt/wt wt/wt wt/*2 *4/*4 *4/*5B
M00995-P FOP Male 62 79% 90% 11 139 NT NT 19 0.18 39 14 37 NT 80 452 98 45 3 11 7 3 17 8 59 wt/wt wt/*2 wt/wt *4/*10 *6A/*6A
F00995-P GNA Female 71 83% 85% 72 131 NT NT 37 27 20 17 62 NT 173 473 100 2.98 0.87 19 4 4 16 8 76 NT NT NT *4/*14A *4/*4
F00995-P OSI Female 48 84% 80% 23 113 NT NT 30 26 18 21 66 NT 34 368 39 0.494 2.141 4 NT 9 NT NT NT wt/wt wt/wt wt/*2 *4/*10 *4/*7B
F00995-P VNL Female 48 84% 80% 23 127 NT NT 32 29 20 21 77 NT 43 396 46 11 1 3 NT 7 NT NT NT wt/wt wt/wt wt/*2 *4/*10 *4/*7B
F00995-N BEB Female 7 84% 90% 11 122 NT NT 56 108 6 10 315 NT 209 483 22 17 18 NT NT NT 17 9 23 NT wt/wt NT *10/*10 *12A/*12A
Download